Hemophilia a Trials in Chicago, United States
Conditions / Hemophilia a / Chicago, United States
Hemophilia a has been the subject of sustained clinical investigation across multiple research sites.
31 total trials for this combination
Showing top 10 of 31 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02615691 | A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A | COMPLETED | PHASE3 |
| NCT01945593 | BAX 855 Continuation | COMPLETED | PHASE3 |
| NCT05911763 | A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A | ACTIVE_NOT_RECRUITING | — |
| NCT03818529 | ATHN 8: Previously Untreated Patients (PUPs) Matter Study | COMPLETED | — |
| NCT00157157 | Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients | COMPLETED | PHASE3 |
| NCT03370913 | Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301) | COMPLETED | PHASE3 |
| NCT04644575 | Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00623480 | Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment | COMPLETED | PHASE3 |
| NCT03417245 | A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors | COMPLETED | PHASE3 |
| NCT02172950 | An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A | COMPLETED | PHASE3 |